לברסט

Страна: Израиль

Язык: иврит

Источник: Ministry of Health

Активный ингредиент:

LETROZOLE 2.5 MG

Доступна с:

RAFA LABORATORIES LTD

код АТС:

L02BG04

Фармацевтическая форма:

FILM COATED TABLETS

Администрация маршрут:

PER OS

Производитель:

SIEGFRIED GENERICS ( MALTA) LTD

Терапевтическая группа:

LETROZOLE

Терапевтические показания :

Letrozole tablets are indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Дата Авторизация:

2012-04-01